Replies to post #1022 on BioCardia Inc (BCDA)

[realfast95]

I'm not a medical person, so bear with me. It appears CardiAMP competes with $VCEL product ixmyelocel-T.

$VCEL completed the Phase 2 last year and had primary endpoint success with the Heart (left side) therapeutic. But did not meet the secondary endpoint Walk Test (no difference than control). $VCEL investors think they can get FDA approval without Phase 3. But I don't see how with CardiAMP in Phase 3.

I can't find any information on CardiAMP Phase 2.
And I believe the CardiAMP Phase 3, Primary endpoint is the Walk.

Can anyone provide me with more clarity? Thanks.